What is Trayt?
Trayt operates at the intersection of clinical research and digital health, providing a patient-centric data analytics ecosystem designed to improve diagnostic accuracy and treatment efficacy for individuals with autism, ADHD, and other neurodevelopmental conditions. By creating sophisticated tools that track, measure, and share behavioral and medical outcomes, the company bridges the gap between fragmented care systems. Its platform empowers clinicians, families, and researchers to move beyond subjective assessments, fostering a data-driven approach to personalized medicine that enhances the overall quality of life for patients within the behavioral health landscape.
How much funding has Trayt raised?
Trayt has raised a total of $7.2M across 1 funding round:
Private Equity
$7.2M
Private Equity (2026): $7.2M, investors not publicly disclosed
Key Investors in Trayt
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Trayt?
Following this major enterprise-level funding, Trayt is poised to scale its operational infrastructure and expand its clinical footprint. The strategic allocation of this capital will likely focus on enhancing the platform's predictive modeling capabilities and deepening integration with existing healthcare delivery networks. As the company transitions into this next phase of growth, the focus will remain on establishing its analytics suite as the industry standard for measuring treatment outcomes in neurodevelopmental care, ultimately driving better long-term health trajectories for a historically underserved patient population.
See full Trayt company page
